399O Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in elderly patients: A subgroup analysis from TOSCA trialGerardo Rosati, Roberto Labianca, Monica Ronzoni et al.|Annals of Oncology|2020Cited by 5
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trialGerardo Rosati, Roberto Labianca, Chiara Alessandra Cella et al.|Gastric Cancer|2022Cited by 4